Concepedia

Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial

Ildiko Lingvay, Andrei‐Mircea Catarig, Juan P. Frías, Harish Kumar, Nanna L. Lausvig, Carel W. le Roux, Desirée Thielke, Adie Viljoen, Rory J. McCrimmon

The Lancet Diabetes & Endocrinology · 2019 · 291 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, David A. D’Alessio, Judith Fradkin et al. · Diabetes Care · 2018 · 3.5K citations · Full text

, , +17

9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2022</i>

Diabetes Care · 2021 · 1.5K citations

, , +13

6. Glycemic Targets: <i>Standards of Medical Care in Diabetes—2022</i>

Diabetes Care · 2021 · 1.4K citations · Full text

, , +15

The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss

Anna Secher, Jacob Jelsing, Arian F. Baquero et al. · Journal of Clinical Investigation · 2014 · 932 citations

, , +17

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial

Richard E. Pratley, Vanita R. Aroda, Ildiko Lingvay et al. · The Lancet Diabetes & Endocrinology · 2018 · 764 citations

, , +13